A.R.T. Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,825	Closed	-$11K	–	181
2020 Q2	$11K	Buy	+12,825	New	+$11.3K	0.02%	271
2020 Q1	–	Sell	-32,225	Closed	-$29K	–	561
2019 Q4	$29K	Buy	32,225 +19,594	+155%	+$16.3K	﹤0.01%	1272
2019 Q3	$12K	Sell	12,631 -17,100	-58%	-$17.7K	﹤0.01%	1383
2019 Q2	$33K	Buy	+29,731	New	+$34.3K	﹤0.01%	1274
2019 Q1	–	Sell	-53,313	Closed	-$49K	–	1464
2018 Q4	$49K	Buy	+53,313	New	+$81.7K	﹤0.01%	1218
2018 Q3	–	Sell	-13,294	Closed	-$23K	–	1553
2018 Q2	$23K	Sell	13,294 -87,331	-87%	-$176K	﹤0.01%	1359
2018 Q1	$236K	Sell	100,625 -13,819	-12%	-$32.4K	0.01%	1217
2017 Q4	$215K	Buy	114,444 +85,476	+295%	+$187K	0.01%	1138
2017 Q3	$71K	Sell	28,968 -7,247	-20%	-$18K	﹤0.01%	1233
2017 Q2	$99K	Buy	+36,215	New	+$101K	0.01%	1255